BACKGROUND Worldwide more than 70 million couples suffer from infertility, the majority
being residents of developing countries. Negative consequences of childlessness are …

OBJECTIVE: To compare the effectiveness of letrozole and clomiphene citrate (CC) in
induction of ovulation in polycystic ovary syndrome (PCOS). DESIGN: Prospective …

Objectives The objective of this study was to compare the efficacy of letrozole versus
clomiphene citrate as an ovulation induction drug in polycystic ovarian syndrome (PCOS) …

The aromatase inhibitor letrozole is a novel agent that can be used as an alternative to
clomiphene citrate for ovulation induction in patients with unexplained infertility. The dose of …

Treatments for infertility vary in their intensity, invasiveness and associated risks. Treatment
can range from medication to induce ovulation to invasive manipulation of eggs and sperm …

OBJECTIVE: To determine the effect of combined therapy of letrozole (2.5 mg or 5.0 mg) with
recombinant follicle-stimulating hormone (FSH) in comparison with the administration of …

Рассмотрена роль эндокринных факторов в формировании различных форм мужского
и женского бесплодия. Определены подходы к диагностике эндокринных нарушений …

Objective. Dose adjustment for induction of ovulation is one of the most important problem.
Methods. In a prospective interventional study, 44 clomiphene‐resistant infertile patients …

Background: Letrazole is an aromatase inhibitor, which is useful in ovulation induction.
However, evidence on its efficacy over clomiphene citrate, which is the first of drug used for …

Background: Luteinized unruptured follicle (LUF) syndrome is considered a cause of
ovulation failure and a subtle cause of infertility. Preovulatory injection of human chorionic …